Omeros Corp
OMER- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001285819
In the last 90 days, Omeros Corp insiders filed 0 open-market purchases and 6 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $343.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Omeros Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +5 vs. Q1 2024
- Shares held
- 25.0M
- −490.3K (−1.9%) vs. Q1 2024
- Total value
- $101.4M
- +$13.6M (+15.4%) vs. Q1 2024
- New holders
- 17
- 24 more added
- Sold out
- 12
- 32 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OMER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 171 | $343.0M |
| Q1 2026 | 162 | $326.2M |
| Q4 2025 | 151 | $570.3M |
| Q3 2025 | 133 | $134.7M |
| Q2 2025 | 128 | $87.3M |
| Q1 2025 | 137 | $226.7M |
| Q4 2024 | 128 | $262.3M |
| Q3 2024 | 108 | $99.3M |
| Q2 2024 | 104 | $101.4M |
| Q1 2024 | 99 | $87.8M |
| Q4 2023 | 97 | $81.7M |
| Q3 2023 | 100 | $78.9M |
| Q2 2023 | 103 | $142.8M |
| Q1 2023 | 91 | $94.9M |
| Q4 2022 | 98 | $44.4M |
| Q3 2022 | 94 | $64.7M |
| Q2 2022 | 102 | $66.0M |
| Q1 2022 | 129 | $173.2M |
| Q4 2021 | 139 | $202.2M |
| Q3 2021 | 142 | $417.7M |
| Q2 2021 | 152 | $478.4M |
| Q1 2021 | 152 | $618.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Omeros Corp; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stifel Financial Corp | 1,902,594 | $7.72M | 0.01% | −6,535−0.3% | Reduced |
| Vanguard Group Inc | 3,219,118 | $13.1M | 0.00% | −31,166−1.0% | Reduced |
| BlackRock Inc. | 4,101,584 | $16.7M | 0.00% | −109,538−2.6% | Reduced |
| Ingalls & Snyder LLC | 4,593,148 | $18.6M | 0.81% | −104,992−2.2% | Reduced |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −178,818−100.0% | Sold out |
| Sheaff Brock Investment Advisors, LLC | 0 | $0 | 0.00% | −60,125−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −30,002−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −20,823−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −20,012−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,315−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,938−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,091−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,672−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |